Cardiac Amyloidosis Screening
Diagnostic evaluation for amyloid protein deposition in cardiac tissue, increasingly important in elderly patients with heart failure.
Full Definition
Cardiac amyloidosis screening involves a systematic approach to detect amyloid protein deposition in the myocardium, a condition that has gained recognition as an under-diagnosed cause of heart failure in elderly populations. The screening process typically includes clinical assessment for red-flag symptoms, echocardiographic evaluation for characteristic features like increased wall thickness with preserved or reduced ejection fraction, and biomarker testing. Advanced imaging with cardiac MRI and nuclear scintigraphy may be employed. Given the availability of disease-modifying treatments for certain types of cardiac amyloidosis, early detection through systematic screening has become a priority in geriatric cardiology practice.
Usage
Usage note: Emphasize systematic approach rather than isolated testing.
In Context
- "The geriatric cardiology clinic implemented a protocol for cardiac amyloidosis screening in all patients over 75 with unexplained heart failure." — Quality improvement protocol
- "Cardiac amyloidosis screening should be considered in elderly patients with heart failure and preserved ejection fraction." — Clinical practice guideline